The discovery and development of powerful immunotherapies for all types of cancer requires information and dialogue. Cancer Research Institute print and online resources make it easy to stay up-to-date on cancer immunotherapy research and treatment. CRI also offers information specifically for patients and their families, as well as for current and prospective donors.
Do you want to help create a future immune to cancer and save more lives? Consider working at the Cancer Research Institute by exploring our open positions. Start your career ir make the next great move by joining our team. See our available positions here.
If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
A browser plugin may be required for the PDF file found this page.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
A recent diabetes-related discovery by CRI Lloyd J. Old STAR Dr. Andrea Schietinger has promising implications for cancer immunotherapy
Rare and ultra-rare cancers affect around 20,000 people in the United States alone, according to Foundation Medicine, Inc. Immunotherapy research in some of the more common cancers and the identification of biomarkers that can predict patient responses is opening this new approach to cancer treatment up to patients whose cancers currently receive little direct attention.